Cencora医药 COR
$333.56 −$6.12 (-1.80%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $333.56 0.00%
开盘$333.61
昨收$339.68
当日区间$332.67 – $338.54
成交量1.68M
市值$63.65B
市盈率（TTM）18.6
股息率0.72%
基本面
最新报告季度：Q3, ended Jun 2026
营收$84.75B+5.1% YoY
营业利润$1.21B+23.0% YoY
净利润$776.67M+12.6% YoY
摊薄每股收益$3.94+11.9% YoY
自由现金流$2.43B+3,382.5% YoY
经营现金流$2.65B
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率4.0%
营业利润率1.4%
净利率0.8%
净资产收益率104.3%
资产收益率3.3%
投入资本回报率23.5%
流动比率0.93
负债/资产比率96.1%
现金及投资$2.82B
总负债$11.72B
净现金（净负债）-$8.91B
自由现金流/营收1.2%
营收构成
2026/Q3 季度
按业务线
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $84.75B | $78.36B | $85.93B | $321.33B | $83.73B |
| 营业总收入 | $84.75B | $78.36B | $85.93B | $321.33B | $83.73B |
| 营业成本 | $81.15B | $74.77B | $82.86B | $309.85B | $80.77B |
| 毛利润 | $3.61B | $3.59B | $3.07B | $11.48B | $2.95B |
| 营业费用 | $2.40B | $2.23B | $2.06B | $7.54B | $2.01B |
| 销售及管理费用 | $2.13B | $1.98B | $1.80B | $6.49B | $1.75B |
| 折旧、摊销与折耗 | $269.50M | $249.29M | $260.40M | $1.05B | $258.77M |
| -折旧与摊销 | $269.50M | $249.29M | $260.40M | $1.05B | $258.77M |
| 营业利润 | $1.21B | $1.36B | $1.02B | $3.93B | $945.94M |
| 非经营性利息净收入（支出） | -$140.71M | -$140.46M | -$72.41M | -$291.55M | -$77.83M |
| 非经营性利息收入 | $13.82M | $13.88M | $20.95M | $128.21M | $31.53M |
| 非经营性利息支出 | $154.52M | $154.34M | $93.36M | $419.75M | $109.36M |
| 其他收入（支出） | -$68.17M | $867.54M | -$235.33M | -$1.38B | -$1.06B |
| 特殊收益（费用） | -$85.05M | -$218.90M | -$255.93M | -$1.31B | -$927.44M |
| -减：重组及并购费用 | $173.70M | $205.04M | $92.59M | $520.47M | $189.15M |
| -减：其他特殊支出 | -$88.64M | $13.86M | -$86.15M | $60.67M | $14.41M |
| -减：核销 | $0.00 | $0.00 | $249.50M | – | – |
| 其他非经营性收入（支出） | $16.88M | $1.09B | $20.60M | -$78.72M | -$127.71M |
| 税前利润 | $996.39M | $2.09B | $708.64M | $2.26B | -$187.04M |
| 税费 | $219.73M | $459.04M | $142.51M | $690.52M | $146.03M |
| 净利润 | $776.67M | $1.63B | $566.13M | $1.57B | -$333.07M |
| 持续经营利润 | $776.67M | $1.63B | $566.13M | $1.57B | -$333.07M |
| 少数股东权益 | $13.15M | -$11.80M | $6.48M | $13.65M | $6.63M |
| 归属母公司净利润 | $763.52M | $1.64B | $559.65M | $1.55B | -$339.70M |
| 归属普通股股东净利润 | $763.52M | $1.64B | $559.65M | $1.55B | -$339.70M |
| 基本每股收益 | $3.95 | $8.44 | $2.88 | $8.02 | -$1.75 |
| 摊薄每股收益 | $3.94 | $8.40 | $2.87 | $7.96 | -$1.75 |
| 每股股息 | $0.60 | $0.60 | $0.60 | $2.20 | $0.55 |
| -减：资本性资产减值 | – | – | – | $723.88M | – |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $83.81B | $81.65B | $78.36B | $76.59B | $76.59B |
| 流动资产合计 | $55.34B | $53.14B | $54.15B | $52.24B | $52.24B |
| 现金及现金等价物与短期投资 | $2.82B | $2.18B | $1.75B | $4.36B | $4.36B |
| -现金及现金等价物 | $2.82B | $2.18B | $1.75B | $4.36B | $4.36B |
| 应收款 | $25.45B | $24.89B | $25.98B | $25.23B | $25.23B |
| -应收账款 | $25.45B | $24.89B | $25.98B | $25.23B | $25.23B |
| 存货 | $21.03B | $20.01B | $24.08B | $20.49B | $20.49B |
| 其他流动资产 | $2.21B | $2.21B | $2.34B | $2.17B | $2.17B |
| 非流动资产合计 | $28.47B | $28.51B | $24.21B | $24.35B | $24.35B |
| 固定资产净值 | $2.84B | $2.81B | $2.45B | $2.54B | $2.54B |
| 商誉及其他无形资产 | $22.45B | $22.51B | $17.41B | $17.45B | $17.45B |
| -商誉 | $16.52B | $16.45B | $13.73B | $13.68B | $13.68B |
| -其他无形资产 | $5.93B | $6.05B | $3.68B | $3.77B | $3.77B |
| 一年以上递延资产 | $179.42M | $192.83M | $206.82M | $208.81M | $208.81M |
| 其他非流动资产 | $3.01B | $3.01B | $4.14B | $4.15B | $4.15B |
| 负债合计 | $80.57B | $78.07B | $76.27B | $74.84B | $74.84B |
| 流动负债合计 | $59.20B | $56.13B | $59.13B | $57.82B | $57.82B |
| 应付款 | $54.70B | $51.88B | $56.06B | $54.72B | $54.72B |
| -应付账款 | $54.70B | $51.88B | $56.06B | $54.72B | $54.72B |
| 一年内应计费用 | $3.35B | $3.20B | $2.73B | $2.98B | $2.98B |
| 短期债务及融资租赁负债 | $279.16M | $202.66M | $342.28M | $117.79M | $117.79M |
| -一年内到期债务 | $279.16M | $202.66M | $342.28M | $117.79M | $117.79M |
| 其他流动负债 | $869.70M | $851.95M | – | – | – |
| 非流动负债合计 | $21.37B | $21.93B | $17.13B | $17.02B | $17.02B |
| 长期应付账款及其他应付款 | $395.99M | $352.77M | $351.49M | $337.63M | $337.63M |
| 一年以上应计费用 | $3.77B | $3.86B | $3.87B | $3.88B | $3.88B |
| 长期债务及融资租赁负债 | $11.44B | $12.18B | $7.58B | $7.54B | $7.54B |
| -长期债务 | $11.44B | $12.18B | $7.58B | $7.54B | $7.54B |
| 一年以上递延负债 | $1.79B | $1.75B | $1.64B | $1.62B | $1.62B |
| 其他非流动负债 | $3.97B | $3.79B | $3.70B | $3.64B | $3.64B |
| 股东权益合计 | $3.24B | $3.58B | $2.10B | $1.75B | $1.75B |
| 股东权益 | $3.05B | $3.40B | $1.91B | $1.51B | $1.51B |
| 股本 | $2.98M | $2.98M | $2.98M | $2.97M | $2.97M |
| -普通股 | $2.98M | $2.98M | $2.98M | $2.97M | $2.97M |
| 资本公积 | $6.34B | $6.30B | $6.27B | $6.20B | $6.20B |
| 留存收益 | $9.14B | $8.49B | $6.97B | $6.53B | $6.53B |
| 减：库存股 | $11.45B | $10.44B | $10.43B | $10.33B | $10.33B |
| 不影响留存收益的损益 | -$979.74M | -$961.31M | -$905.08M | -$901.38M | -$901.38M |
| 少数股东权益 | $188.13M | $187.36M | $187.64M | $239.07M | $239.07M |
| -固定资产原值 | – | – | – | $5.73B | $5.73B |
| -累计折旧 | – | – | – | -$3.19B | -$3.19B |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | $2.65B | $1.34B | -$2.31B | $3.88B | $3.13B |
| 持续经营经营活动现金流净额 | $2.65B | $1.34B | -$2.31B | $3.88B | $3.13B |
| 持续经营净利润 | $776.67M | $1.63B | $566.13M | $1.57B | -$333.07M |
| 持续经营损益 | $142.78M | -$42.37M | -$4.18M | $130.31M | $63.25M |
| 折旧、折耗与摊销 | $277.43M | $262.98M | $264.27M | $1.07B | $264.00M |
| 递延税款 | $54.88M | $178.41M | $14.36M | $59.86M | $55.39M |
| 其他非现金项目 | -$189.96M | -$1.19B | -$62.11M | -$35.35M | -$28.35M |
| 营运资金变动 | $1.55B | $481.25M | -$3.40B | $35.42M | $2.23B |
| -应收款变动 | -$445.95M | $522.08M | -$830.75M | -$1.92B | -$945.80M |
| -存货变动 | -$886.86M | $3.40B | -$3.52B | -$1.27B | -$319.55M |
| -预付资产变动 | $107.73M | $68.49M | -$14.39M | $173.86M | -$63.96M |
| -应付账款及应计费用变动 | $2.88B | -$3.51B | $965.78M | $3.46B | $3.96B |
| 投资活动现金流净额 | -$240.15M | -$4.87B | -$299.32M | -$4.98B | -$321.94M |
| 持续经营投资活动现金流净额 | -$240.15M | -$4.87B | -$299.32M | -$4.98B | -$321.94M |
| 资本支出 | -$226.04M | -$165.62M | -$119.38M | -$667.98M | -$249.81M |
| 业务购买及出售净额 | -$25.93M | -$4.72B | -$230.40M | -$4.29B | -$93.86M |
| 其他投资变动净额 | $11.82M | $11.57M | $50.46M | -$17.44M | $21.73M |
| 筹资活动现金流 | -$1.77B | $3.98B | $43.20M | $2.25B | -$683.78M |
| 持续经营筹资活动现金流净额 | -$1.77B | $3.98B | $43.20M | $2.25B | -$683.78M |
| 债务发行及偿还净额 | -$648.21M | $4.11B | $266.21M | $3.20B | -$582.24M |
| 普通股发行净额 | -$1.00B | $0.00 | $0.00 | -$435.47M | $0.00 |
| 已付现金股利 | -$116.59M | -$117.46M | -$126.52M | -$437.08M | -$107.51M |
| 其他筹资费用净额 | -$2.98M | -$7.93M | -$104.09M | -$103.14M | -$23.17M |
| 期末现金余额 | $2.86B | $2.24B | $1.81B | $4.39B | $4.39B |
| 现金净变动 | $646.09M | $442.31M | -$2.56B | $1.15B | $2.13B |
| 期初现金余额 | $2.24B | $1.81B | $4.39B | $3.30B | $2.28B |
| 汇率变动影响 | -$10.69M | $9.75M | -$24.58M | -$50.27M | -$8.47M |
| 自由现金流 | $2.43B | $1.17B | -$2.42B | $3.21B | $2.88B |
| 股票期权行使所得 | – | – | $7.60M | $29.13M | $6.52M |
| -其他流动负债变动 | – | – | – | -$404.10M | -$404.10M |
暂无评论——快来第一个聊聊 COR。
登录后参与讨论。